Copley Scientific has announced that it will introduce the new Child Alberta Idealised Throat for inhaler testing at Drug Delivery to the Lungs 24 along with its recently introduced TPK-R critical flow controller.
The child version of the Alberta Idealised Throat (AIT) is designed to provide cascade impactor data with greater in vivo relevance for pediatric patients. Both Alberta throats can be used to replace the standard USP induction port to obtain more realistic simulations of deposition in the upper respiratory tract.
Read the Copley Scientific press release.
